Winship Cancer Institute of Emory University
winshipcancer.emory.edu
As Georgia’s only NCI-Designated Comprehensive Cancer Center, we are dedicated to the prevention, treatment and control of cancer. #WhereScienceBecomesHope https://winshipcancer.emory.edu
👤 Joined on 20 November 2024
494
Followers
132
Following
114
Total Posts
📜 Kullanıcı Geçmişi
- 20 Kas 2024, 19:35
🎉 Bluesky'e katıldı - İlk kullanıcı adı:
@winshipatemory.bsky.social - 24 Nis 2025, 12:29
✏️ Kullanıcı adı değişti:
@winshipatemory.bsky.social→@winshipcancer.emory.edu
🚫 Blokladığı Kullanıcılar
❤️ Beğendiği Gönderiler
An evolving understanding of resistance mechanisms is shaping ROS1-positive NSCLC care, according to @latinamd.bsky.social and other experts. @winshipcancer.emory.edu @danafarber.bsky.social @moffittnews.bsky.social #lcsm #oncology Read the full story ➡️: www.onclive.com/view/compreh...
Show Post
ASCO experts Dr. Lesnock of @upmc.com and Dr. Scalici of @winshipcancer.emory.edu explain the New ASCO Living Guideline: Systemic Treatment of Ovarian Cancer Recurrence and the data behind the recommendations. Read the full guideline: https://bit.ly/4c5RdYe
Show PostWATCH: @kalinskykevin.bsky.social, of @winshipcancer.emory.edu, highlights updated data with sacituzumab govitecan plus pembrolizumab in previously untreated TNBC. Read our coverage of these data for more insights! @ascocancer.bsky.social #ASCO26 #bcsm #oncology www.onclive.com/view/sacituz...
Show Post
Retraction is not refutation: Why chrono-immunotherapy still deserves scientific investigation By Zachary S. Buchwald and Michael C. Lowe (@winshipcancer.emory.edu) https://cancerletter.com/trials-and-tribulations/20260731_3/
Show PostBuchwald/Lowe (@winshipcancer.emory.edu): "The recent retraction of the LungTIME-C01 randomized trial...has ignited a vigorous debate regarding the promise of cancer chronotherapy." https://cancerletter.com/trials-and-tribulations/20260731_3/
Show Post